Methodological issues in the monetary valuation of benefits in healthcare
- 1 December 2003
- journal article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 3 (6) , 717-727
- https://doi.org/10.1586/14737167.3.6.717
Abstract
Economic evaluation is concerned with comparing the costs and benefits of competing healthcare interventions in order to efficiently allocate resources. Whilst valuing costs is important, the valuation of benefits represents one of the greatest challenges facing health economists. This review considers the different techniques available for the valuation of healthcare benefits in monetary terms, and more specifically the contingent valuation method and discrete choice experiments. This review identifies some of the key issues and debates that have been published in the literature concerning the application of the techniques to healthcare and highlights important areas for future research.Keywords
This publication has 65 references indexed in Scilit:
- Revealed preference valuation compared to contingent valuation: radon‐induced lung cancer preventionHealth Economics, 2002
- The Creative Destruction of Decision ResearchJournal of Consumer Research, 2001
- Use of discrete choice experiments to elicit preferencesQuality and Safety in Health Care, 2001
- “Communitarian claims” as an ethical basis for allocating health care resourcesSocial Science & Medicine, 1998
- Should government fund assisted reproductive techniques? A study using willingness to payApplied Economics, 1997
- Mark Pauly on welfare economics: Normative rabbits from positive hatsJournal of Health Economics, 1996
- Value for money? A contingent valuation study of the optimal size of the Swedish health care budgetHealth Policy, 1995
- Assessing the Economic Value of a New AntidepressantPharmacoEconomics, 1995
- What Do Patients Value?Medical Care, 1985
- An Experiment in Valuing Senior Companion Program ServicesThe Journal of Human Resources, 1983